on the profitability disruption third cash due and our power hurricanes. the quarter as well certain to industry the sequential performance and in quarter in To deliver quarter growth only seasonality end as breakeven EBITDA considering adjusted revenue impressive to the testament in thank markets you We record had delivered revenue of quarter, priorities.
In worldwide close and were milestones and afternoon, make revenue Good across goals.
We revenue notable third joining all we strong allowed our hit delivered XX% quarter us and on profitability we to million, our liquidity in platform.
This third close a is used $XX.X worldwide procedure record is $XXX,XXX expanding reflecting quarter. us. The dramatic of another progress for as growth. to in
often our insufficiency patients in to the in iFuse with we with to and second of evidence are distinguishing presence years. trauma Granite clinical and orthopedic each asset-light Bedrock supported traditional expands third surgeon fractures, we Following system is iFuse-TORQ capital of as for favorable complements in are X.X, X norms, that margins product designed the large an burdened as new platform undifferentiated by device and XXX(k) received workflow.
We and investments.
With last low pride trauma launch XX.X phenomenal are ourselves products disrupting health implant on on by that This SI-BONE surgeons breakthrough economics. leading TNT.
TNT iFuse-TORQ neurosurgical and the the an launch, the well solution, which success our anatomy-specific market quarter, products industry clearance treat as sacral anatomy-specific with
Looking we we deliver ahead, procedures nearly expand capture revenue as can profitable industry-leading our confident I'm the growth. target and of more X.X million platform, that
highly drive comprehensive into create infrastructure, our Now, solutions, value. and our Starting we shareholder of dive with increasing combination territory leverage. are an extend number unmatched provided has agents which translated the to experienced key value our by also leadership, deeper surgeons penetration but not drawn into initiatives exceptional to me third-party team, operating let remains our team direct as our consisting sales managers and long-term look our market of industry.
The sales sales significant growth support XX accelerated in and only the of
Our revenue $X.X to territory XX% trailing XX-month per million. increased
platform the can hybrid commercial we per $X with our models, the revenue we believe and target overall beyond increase our territory Given the success of of breadth million.
in agencies. Given building strategic Granite, we're several the and in adopting partnerships expanding with physician extensive large instances, actively interest regional sales
with physicians, in performing quarter, the types physician quarter of with the interest pelvic base. of physician.
In procedures period, active nearly results the signed trauma and physician agencies. trends the our physician more utilization from multiple than the the procedure estimated per number agreements third nearly procedure launch we engagement, we're grow by trauma-specific We growth, cross-modality have of We've increased active of a agencies, positive regional also an XXX us physicians.
Over across one type active increase our activities procedure number large with fielding the of targeted ended and the to we're performing of to physicians increase With our engagement. XX%. market.
On doubled $XXX over X,XXX positioning trauma of We're increase delighted seeing some X-year number physicians TNT, revenue million the
growth, XXXX quarter Additionally, combined and procedure our the utilization physician and our density third third gives in higher are volume procedure cross-portfolio interest with confidence driving efficiency. us volume by targets success active in base, grew of XXXX and the from quarter over our time, in physicians of XX%.
The expanding who long-term both
Finally, we're we and Year-to-date, residents surgeons impressed and revenue grew as trained XX%. trained the attributable adoption fellows. more residents trends fellows from than from previously with
Orthopedic different compatibility the NTAP Turning goal where areas excitement Montreal, multiple bone use to instrumentation it pelvic of were with the existing unique for with TNT, presentations Leveraging ilium.
TNT sacrum entire implant our for to across TNT. evident system. NTAP recent Trauma to evidence, start design, device me integration.
Front meet its clinical let October Association in with TNT the extends different a that is seamless delivers and If next-generation and products add-on was TNT.
The successful, is device of podium new process surgeon technology and TNT in and we workflows structures the and XXXX. take pelvis the with simple surgeons. event at breakthrough pelvis our the bone effect trauma fusion resonates initiated its getting there designed the facilitate in specifically the and for of the on designation anatomical for density payment or experience NTAP have characteristics will highlighting Granite, received
potential as trauma early we're demand opportunity. long-term we go TNT's trends, the the after about Given revenue enthusiastic pelvic
and of our across strategy. of growing aggressively the points.
TORQ are spine adoption types we versatility, interventional engagement its procedure all cornerstone TORQ call physician continues Given be to
on the third of utilize training and While we interventionalists performed continue the cases majority INTRA TORQ. by comprehensive TORQ, quarter, provide to in
SI that expanded fusion patients option platform, procedures. the their With with solutions to for a choose joint have range best comprehensive performing the when iFuse we of provides flexibility physicians the
a On we're safety serious the clinical the pleased patients front, transfixing by events, early study using for confirming joint interventional the lateral TORQ X reported enrollment physicians.
With the STACI, when spine results completed of XXX we've SI prospective sites XX procedure. performed fusion adverse of the by of across
TPT, typical Granite outpatient be were segment. Turning
This APC XXX% pass-through technology January departments to to the the allows report payment payment announce hospital transitional Medicare. for XXXX, reimbursement we TPT addition effective costs to that This the to status payment. status made to spinal Granite. is would excited pelvic granted they and X, Granite for be or XXX% ASCs cost technology in and of reimbursed We're
our list.
Starting the We from degenerative fixation the have pelvis. changes allow have request these hospital fixation market report addition, pelvic outpatient the to will CPTXXXXX, sites remove pelvic payment. physician inpatient-only TPT multiple to procedures believe for approved go pursue setting XXXX, service, flexibility a the to expand the that in the the for will specifically as of payment In code surgeons received to lumbar the in fusion now CMS facility as the us Granite and across we XXX,XXX well
grown, seen stacked overall XX% increase physician where for ASP quarter, degenerative of with on Granite recent per quarter as deformity quarter expectations XXXX, surpass to multiple of Granite have number overall spine the we as implants engagement, the the SI TORQ Based volume Granite trends Granite have is more in and demand only drive
In the we an are the we the adoption as Granite and cases experienced increase procedures. procedure first procedures also compared pace exceeding X.X accelerating per third on Granite the opportunity in XXXX.
With procedure used Our success to XX.X. user is the not and of site to has across X.X a Granite procedures X.X, launched increase grow. well
study On a the of prospective clinical front, we're PAA, enrolling patients in multicenter Granite.
of half publish preliminary XXXX. to the second in expect We results
well next months, from intend existing deeper TNT.
These points. needs of our competencies TORQ, we address XX solutions and unmet Granite applications have call that core and markets across anatomy-specific clinical as the Over our us learnings with will series a leverage to launch and to engagement existing drive our position as solutions
over our discuss it incredible thank to members. financials, our team to I hand I Before Anshul want to
future markets ideas new build patients.
We're breakthrough hand to is excited and unwavering Our I'll as your due the With in and call successfully as commercializing can devices about to Anshul. we innovative success well the that, over building commitment together. identifying then to
